当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 资产负债表

凯普生物

(300639)

  

流通市值:38.49亿  总市值:39.18亿
流通股本:6.35亿   总股本:6.47亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金764,931,888.81788,454,632.85775,746,540.56932,450,807.46
应收票据及应收账款1,890,591,087.212,259,285,756.982,402,960,172.032,440,343,362.13
其中:应收票据2,485,256.012,283,621.763,253,565.63,049,730
应收账款1,888,105,831.22,257,002,135.222,399,706,606.432,437,293,632.13
预付款项11,359,591.9220,444,838.7818,245,468.3124,663,814.96
其他应收款合计13,560,430.6620,356,217.0224,019,701.7816,596,579.32
应收股利--5,168,800-
存货99,557,906.71120,773,726.97121,430,373.9107,683,973.22
其他流动资产89,869,717.88118,542,573.62121,603,199.09128,308,186.77
流动资产平衡项目0000
流动资产合计3,176,925,297.433,604,905,522.183,729,306,570.814,023,150,407.6
非流动资产:
长期股权投资30,427,412.3830,180,969.2830,142,137.4130,273,154.31
其他权益工具投资288,697,319.54288,737,005.58282,846,711.45283,003,440.82
其他非流动金融资产214,000,000214,000,000214,000,000214,000,000
固定资产1,240,848,457.881,269,586,616.891,276,515,299.071,246,189,227.13
在建工程171,377,982.4132,136,168.1697,141,206.52102,356,893.5
使用权资产25,131,585.1227,122,855.6429,793,479.8733,813,399.43
无形资产249,583,717.5246,178,075.16245,937,767.93235,733,454.25
开发支出27,217,386.1130,041,058.3428,616,769.6735,582,236.75
长期待摊费用52,735,097.346,584,662.5950,227,207.6347,966,222.67
递延所得税资产195,346,003.92185,749,787.53155,669,565.92163,785,062.19
其他非流动资产53,500,758.7419,921,233.2929,854,443.625,911,904.76
非流动资产平衡项目0000
非流动资产合计2,548,865,720.892,490,238,432.462,440,744,589.072,418,614,995.81
资产平衡项目0000
资产总计5,725,791,018.326,095,143,954.646,170,051,159.886,441,765,403.41
流动负债:
短期借款2,118,599.9966,390,147.96100,106,833.32100,180,999.99
应付票据及应付账款143,665,795.99168,677,135.44251,130,835.92335,377,364.04
应付账款143,665,795.99168,677,135.44251,130,835.92335,377,364.04
合同负债8,934,450.0116,626,559.7219,111,582.0116,938,488.53
应付职工薪酬82,211,720.12106,244,604.0298,918,242.3799,558,173.64
应交税费82,897,097.8267,229,677.88269,223,200.56304,685,848.86
其他应付款合计178,553,738.87155,961,952.22139,720,511.09190,340,396.46
应付股利9,560,361.368,274,630.93--
一年内到期的非流动负债8,863,202.297,062,370.567,059,983.289,339,260.96
其他流动负债671,163.9898,894.781,060,215.13,969,506.54
流动负债平衡项目0000
流动负债合计507,915,768.97789,091,342.58886,331,403.651,060,390,039.02
非流动负债:
长期借款28,268,475.3520,012,833.3510,008,888.89-
租赁负债17,402,299.8524,820,980.7127,364,576.828,308,770.74
预计负债46,895.62---
递延收益11,819,592.4112,089,769.3412,770,475.2313,451,180.83
递延所得税负债61,601,702.5791,792,900.8693,387,931.2295,084,689.38
非流动负债平衡项目0000
非流动负债合计119,138,965.8148,716,484.26143,531,872.14136,844,640.95
负债平衡项目0000
负债合计627,054,734.77937,807,826.841,029,863,275.791,197,234,679.97
所有者权益(或股东权益):
实收资本(或股本)649,149,874649,149,874649,149,874439,516,016
资本公积877,518,246.44875,102,345.24878,104,365.161,191,272,455.91
减:库存股100,000,734.93100,000,734.93100,000,734.93153,003,114.92
其他综合收益187,256,870.09189,823,338.45194,677,238.89142,780,793.02
盈余公积87,555,295.256,672,097.9956,672,097.9956,672,097.99
未分配利润3,159,797,302.793,212,705,900.513,169,434,079.993,265,871,925.73
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,861,276,853.594,883,452,821.264,848,036,921.14,943,110,173.73
少数股东权益237,459,429.96273,883,306.54292,150,962.99301,420,549.71
股东权益平衡项目0000
股东权益合计5,098,736,283.555,157,336,127.85,140,187,884.095,244,530,723.44
负债和股东权益合计5,725,791,018.326,095,143,954.646,170,051,159.886,441,765,403.41
公告日期2024-04-242023-10-262023-08-312023-04-25
审计意见(境内)标准无保留意见
TOP↑